Prognosis
GlaxoSmithKline Builds AI Team With Another Hire From Biotech Hotbed
- New AI leader is latest to come from Roche’s Genentech unit
- Revitalizing R&D operations is among CEO Walmsley’s goals
This article is for subscribers only.
GlaxoSmithKline Plc lured another executive from California’s biotech hotbed in a bid to step up its artificial intelligence efforts and revitalize drug research.
Kim Branson will oversee the use of AI to find novel targets for potential medicines, where Glaxo believes the technology can have the biggest impact, the London-based drugmaker said. Branson is the latest top manager Glaxo has recruited from Roche Holding AG’s Genentech unit, based in San Francisco.